---
title: "Propanc Biopharma, Inc. (PPCB.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PPCB.US.md"
symbol: "PPCB.US"
name: "Propanc Biopharma, Inc."
industry: "Biotechnology"
datetime: "2026-06-13T19:42:56.338Z"
locales:
  - [en](https://longbridge.com/en/quote/PPCB.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PPCB.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PPCB.US.md)
---

# Propanc Biopharma, Inc. (PPCB.US)

## Company Overview

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.propanc.com](https://www.propanc.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.27 | 103 | - | - | - |
| PB | 0.53 | 46 | 2.14 | 0.70 | 0.20 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/PPCB.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/PPCB.US/norm.md)
- [Related News](https://longbridge.com/en/quote/PPCB.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/PPCB.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**